Accenture plc (ACN)vsAmgen Inc (AMGN)
ACN
Accenture plc
$192.29
-0.65%
TECHNOLOGY · Cap: $118.34B
AMGN
Amgen Inc
$353.93
+1.58%
HEALTHCARE · Cap: $187.83B
Smart Verdict
WallStSmart Research — data-driven comparison
Accenture plc generates 96% more annual revenue ($72.11B vs $36.75B). AMGN leads profitability with a 21.0% profit margin vs 10.6%. ACN appears more attractively valued with a PEG of 1.55. AMGN earns a higher WallStSmart Score of 70/100 (B-).
ACN
Buy60
out of 100
Grade: C+
AMGN
Strong Buy70
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-19.5%
Fair Value
$160.91
Current Price
$192.29
$31.38 premium
Margin of Safety
+46.8%
Fair Value
$665.50
Current Price
$353.93
$311.57 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Every $100 of equity generates 25 in profit
Attractively priced relative to earnings
Generating 3.7B in free cash flow
Every $100 of equity generates 106 in profit
Strong operational efficiency at 30.5%
Earnings expanding 112.1% YoY
Large-cap with strong market position
Keeps 21 of every $100 in revenue as profit
Areas to Watch
Expensive relative to growth rate
4.0% earnings growth
Weak financial health signals
Expensive relative to growth rate
Trading at 22.0x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : ACN
The strongest argument for ACN centers on Market Cap, Return on Equity, P/E Ratio.
Bull Case : AMGN
The strongest argument for AMGN centers on Return on Equity, Operating Margin, EPS Growth. Profitability is solid with margins at 21.0% and operating margin at 30.5%.
Bear Case : ACN
The primary concerns for ACN are PEG Ratio, EPS Growth, Piotroski F-Score.
Bear Case : AMGN
The primary concerns for AMGN are PEG Ratio, Price/Book.
Key Dynamics to Monitor
ACN profiles as a value stock while AMGN is a mature play — different risk/reward profiles.
ACN carries more volatility with a beta of 1.25 — expect wider price swings.
AMGN is growing revenue faster at 8.6% — sustainability is the question.
ACN generates stronger free cash flow (3.7B), providing more financial flexibility.
Bottom Line
AMGN scores higher overall (70/100 vs 60/100), backed by strong 21.0% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accenture plc
TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA
Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.
Amgen Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Visit Website →Compare with Other INFORMATION TECHNOLOGY SERVICES Stocks
Want to dig deeper into these stocks?